Bromide

Bromide

SCHEMBL1190958

Br.O=C(c1ccc(O)c(Br)c1)N1CCOc2cnccc21

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 8/20 0.64
SLC22A6 Q4U2R8 1/20 0.64
SLC22A8 Q8TCC7 1/20 0.64
POLB P06746 1/20 0.44
NR3C2 P08235 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.41
CTSD P07339 1/20 0.38
KCNH2 Q12809 2/20 0.37
IDO1 P14902 1/20 0.36
CYP11B2 P19099 1/20 0.36
KMT2A Q03164 1/20 0.35
NOTUM Q6P988 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
FAAH O00519 1/20 0.34
NAAA Q02083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1191178 0.99 SLC22A12 (0.65) SLC22A12SLC22A6SLC22A8POLBNR3C2
SCHEMBL1191174 0.94 SLC22A12 (0.59) SLC22A12SLC22A6SLC22A8POLBNR3C2
Bromide SCHEMBL1190077 0.91 SLC22A12 (0.77) SLC22A12SLC22A6SLC22A8POLBNR3C2
SCHEMBL1190488 0.90 SLC22A12 (0.79) SLC22A12SLC22A6SLC22A8POLBNR3C2
Bromide SCHEMBL1191225 0.88 SLC22A12 (0.54) SLC22A12SLC22A6SLC22A8POLBNR3C2
SCHEMBL1190712 0.87 SLC22A12 (0.82) SLC22A12SLC22A6SLC22A8POLBNR3C2
SCHEMBL1191018 0.86 SLC22A12 (0.55) SLC22A12SLC22A6SLC22A8POLBNR3C2
SCHEMBL1190582 0.85 SLC22A12 (0.71) SLC22A12SLC22A6SLC22A8POLBNR3C2
SCHEMBL1191923 0.84 SLC22A12 (0.57) SLC22A12SLC22A6SLC22A8POLBGPBAR1
SCHEMBL1191688 0.84 SLC22A12 (0.52) SLC22A12SLC22A6SLC22A8POLBNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266989-B1 HETEROCYCLIC DERIVATIVES C & C RES LAB (KR) 2015-09-02 EP claimed
US-8394792-B2 Heterocyclic derivatives C&C RESEARCH LABORATORIES (KR) 2013-03-12 US claimed
US-20110028467-A1 HETEROCYCLIC DERIVATIVES C&C RESEARCH LABORATORIES (KR) 2011-02-03 US claimed
EP-2266989-B1 HETEROCYCLIC DERIVATIVES C & C RES LAB (KR) 2015-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028467-A1 HETEROCYCLIC DERIVATIVES XDH, NUDT1, UGDH SLC22A12 692/4885SLC22A6 625/4885SLC22A8 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.